Oncolytics Biotech (ONCY) - 2025 Q1 - Earnings Call Transcript

Oncolytics Biotech (ONCY) Q1 2025 Earnings Call May 14, 2025 04:30 PM ET Company Participants Jon Patton - Director, IR & CommunicationWayne Pisano - Interim CEO & Chairman of the BoardThomas Heineman - Chief Medical OfficerChristophe Degois - VP, Business DevelopmentKirk Look - Chief Financial OfficerPatrick Trucchio - Managing Director Conference Call Participants Michael Freeman - Equity Research Analyst - Healthcare Operator Good afternoon, and welcome to OnClinic's Biotech's First Quarter Conference Ca ...